Latest News of PSTX
Poseida Therapeutics, Inc.'s (NASDAQ:PSTX) institutional investors lost 22% over the past week but have profited from longer-term gains
By Yahoo! Finance |
1 month ago
Research on ownership and analyst forecasts provide insight into stock opportunities. Institutional investors hold 49% of Poseida Therapeutics shares, with hedge funds owning 6.2%. Top shareholders ha...